Crystalline Management Inc. Axonics, Inc. Transaction History
Crystalline Management Inc.
- $76.7 Billion
- Q1 2024
A detailed history of Crystalline Management Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Crystalline Management Inc. holds 33,588 shares of AXNX stock, worth $2.27 Million. This represents 3.02% of its overall portfolio holdings.
Number of Shares
33,588Holding current value
$2.27 Million% of portfolio
3.02%Shares
1 transactions
Others Institutions Holding AXNX
# of Institutions
242Shares Held
41.8MCall Options Held
213KPut Options Held
362K-
Vanguard Group Inc Valley Forge, PA5.04MShares$340 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.29MShares$289 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.81MShares$123 Million4.89% of portfolio
-
Fil LTD Hamilton, D01.72MShares$116 Million0.12% of portfolio
-
Mackenzie Financial Corp Toronto Ontario, A61.27MShares$85.6 Million0.13% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.32B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...